Skip to Main content Skip to Navigation
Journal articles

Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial

Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-01617422
Contributor : David Klatzmann Connect in order to contact the contributor
Submitted on : Monday, October 16, 2017 - 3:25:28 PM
Last modification on : Saturday, November 20, 2021 - 3:50:04 AM

Links full text

Identifiers

Citation

Jean-Sébastien Hulot, Joe-Elie Salem, Alban Redheuil, Jean-Philippe Collet, Shaida Varnous, et al.. Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial. European Journal of Heart Failure, Oxford University Press (OUP), 2017, ⟨10.1002/ejhf.826⟩. ⟨inserm-01617422⟩

Share

Metrics

Record views

553